2020

1. Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

   Medicina Clinica, Vol. 155, Núm. 4, pp. 152-158

2. Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes

   Journal of Molecular Diagnostics, Vol. 22, Núm. 10, pp. 1217-1224

3. Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

   Bone Marrow Transplantation, Vol. 55, Núm. 3, pp. 641-648